Medical imaging equipment — including ultrasound machines, X-ray systems, CT scanners, MRI units and linear accelerators — is central to modern diagnosis and therapy. These devices directly affect clinical decision-making and patient outcomes, and their misuse or poor quality can produce serious harm. In recent years India has moved to tighten oversight of imaging equipment to address safety, quality, traceability and misuse. Strengthened regulation aims to protect patients, improve device performance, and bring India’s regulatory approach closer to global practices.
Historically, imaging equipment in India occupied a regulatory gray area. Some modalities fell under radiology-specific controls (for example, the PCPNDT Act for ultrasound), while others were treated as general electronic/medical products without a consistent device-specific compliance pathway. This patchwork created gaps in traceability, variable quality of installed equipment, and unclear responsibilities for importers, manufacturers and service providers. Government intervention responded to these gaps by formally classifying many imaging devices within the medical device regulatory framework and strengthening the role of the Central Drugs Standard Control Organization (CDSCO) in oversight.
Several practical concerns motivated the regulatory tightening:
Patient safety concerns: Imaging errors, inappropriate exposures and malfunctioning equipment can lead to misdiagnosis, radiation overexposure or delayed treatment.
Quality and traceability issues: Imported or locally manufactured units sometimes lacked consistent test reports, service histories or original manufacturer documentation, complicating corrective action and recall management.
Misuse of ultrasound equipment: Improper use — including illegal prenatal sex determination — has public health and legal implications and requires coordinated device and user oversight.
Technological complexity: Advanced devices (e.g., MRI, linear accelerators) require stringent manufacturing controls, specialized installation, and certified maintenance to operate safely.
Alignment with global norms: Stronger regulation supports exports, helps manufacturers meet international market expectations, and facilitates harmonization with established regulatory systems.
The Drugs Technical Advisory Board (DTAB) serves as a key expert advisory group to the government on drug and device policy. DTAB recommendations inform the legal classification of products under the Drugs and Cosmetics Act, 1940 and subsequent Medical Device Rules. Following expert review and public health inputs, DTAB advised that a broad range of imaging systems be treated as regulated medical devices. This legal classification places imaging equipment within the remit of CDSCO and state licensing authorities and subjects them to defined registration, manufacturing and import controls.
Under the strengthened framework, many imaging products are now clearly included in the definition of medical devices. Covered products typically include:
Diagnostic equipment: ultrasound machines, X-ray units, CT scanners, MRI systems, C-arms, mammography systems.
Therapeutic and hybrid systems: linear accelerators, image-guided radiotherapy systems.
Associated accessories and software that materially influence device performance (e.g., image reconstruction or dose-management modules).
The scope also extends to the supply chain: importers, distributors, service providers and aftermarket component suppliers are brought into compliant oversight so that the entire lifecycle — from manufacture to servicing — is governed by regulatory requirements.
With imaging equipment classified as medical devices, manufacturers and importers must follow defined CDSCO registration and compliance steps. Key expectations generally include:
Regulatory registration or licensing: Device listing/registration with CDSCO and, where applicable, import authorizations and manufacturing licenses under the Medical Device Rules.
Quality management systems: Implementation of an appropriate QMS, typically aligned with ISO 13485, to ensure controlled design, production, and servicing processes.
Product testing and standards compliance: Conformance to recognized technical and safety standards (electrical safety, electromagnetic compatibility, imaging performance tests, radiation safety standards such as IEC/ISO family norms).
Technical documentation: A technical file or dossier containing device description, intended use, manufacturing processes, risk management (ISO 14971), verification/validation reports, clinical or performance data where applicable, and labeling/IFU.
Post-market surveillance and vigilance: Mechanisms for complaint handling, adverse event reporting, field safety corrective actions and periodic performance reviews.
Service and installation controls: Requirements for qualified installation, commissioning, preventive maintenance and calibration records to ensure safe operation over the device lifecycle.
Regulatory authorities may require site inspections and review of test reports from accredited laboratories prior to approvals.
Addressing misuse — particularly of ultrasound for illegal sex determination — remains a key driver of policy. The regulatory response is multi-pronged:
Device traceability: Mandating registration and unique device identification (UDI) or record-keeping that links equipment to an owner/operator and location makes it easier to audit and trace devices involved in misuse.
Operator credentials and facility licensing: Strengthening linkage between device registration and facility/operator licenses ensures only authorized practitioners use certain modalities. The Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act continues to govern the use of prenatal diagnostic tools, and imaging regulation complements these legal controls.
Data and access controls: Imaging systems increasingly integrate digital storage and networking; controls to restrict unauthorized access and audit imaging logs help detect and deter improper use.
Public health reporting: Mandated reporting channels and periodic audits improve transparency and allow authorities to act swiftly when misuse is identified.
The regulatory strengthening has substantial operational implications:
Increased documentation and evidence requirements: Dossiers must be more complete, with test data, risk analyses, and clinical/performance justification where applicable.
Quality and manufacturing controls: Manufacturers must demonstrate robust process controls, supplier qualification and production traceability consistent with ISO 13485 practices.
Higher compliance costs and timelines: Pre-submission testing, third-party lab reports and regulatory submission preparation can increase time-to-market and associated costs.
Service and after-sales obligations: Firms must ensure trained service personnel, calibration schedules and spare parts availability; distributors and importers must retain records for regulatory inspection.
Market access benefits: Conversely, compliant firms gain greater acceptance in public procurements, smoother customs/clearance processes and improved prospects for export.
Tighter regulation yields multiple benefits for the health ecosystem:
Improved patient safety: Better-regulated devices reduce the incidence of device-related adverse events and ensure consistent imaging quality.
Transparency and traceability: Registration and record-keeping make it simpler to investigate incidents and enact recalls or field corrections.
Alignment with global standards: Harmonized technical and quality requirements facilitate exports and integration into international supply chains.
Quality improvement incentives: Manufacturers are motivated to invest in design controls, testing and staff training, which elevates the overall industry standard.
Public trust: Clear oversight reassures clinicians, hospitals and patients regarding device performance and safety.
The decision to strengthen regulation of imaging equipment in India represents a pragmatic alignment of public health priorities, patient safety and industrial policy. By bringing imaging systems clearly within the medical device framework, the government has closed regulatory gaps, improved traceability and set clear expectations for manufacturers, importers and service providers. These changes impose additional responsibilities — notably enhanced technical documentation, testing, QMS implementation and post-market vigilance — but they also create a more transparent and reliable ecosystem that supports both domestic healthcare needs and export ambitions.
Manufacturers and stakeholders navigating the updated landscape may benefit from expert regulatory guidance to align technical files, quality systems and service practices with current CDSCO imaging equipment registration requirements. For practical, standards-based assistance in documenting and meeting imaging equipment regulatory expectations in India, resources such as CDSCO regulation for imaging equipment in India can provide helpful insights and clarification. Additionally, firms offering compliance support, including Operon Strategist, help translate regulatory requirements into implementable processes that support safe and compliant imaging device deployment.
© 2025 Crivva - Hosted by Airy Hosting Managed Website Hosting.
